FIFilingIndexScreener · The Ledger
🔔 Save search
More filtersthe deep cuts
Valuation▼
P/SAny
FCF yieldAny
EV / EBITDAAny
Profitability▼
Gross marginAny
Net marginAny
Growth▼
Rev growthAny
Balance sheet▼
Debt / EquityAny
Dividend▼
Dividend yieldAny
Listing▼
Exchange
Country
Filter
194 of 3,901
Sort
01
LLYELI LILLY & Co🔥
Healthcare · Pharmaceuticals
$1.01T-2.5%
P/E 49.0·P/S 15.5·Mgn 31.7%·ROE 77.8%·FCF —
F 8
02
ABBVAbbVie Inc.🔥
Healthcare · Pharmaceuticals
$402.35B-1.1%
P/E 110.5·P/S 6.4·Mgn 5.8%·ROE —·FCF 4.4%
F 7
03
UNHUNITEDHEALTH GROUP INC🔥
Healthcare · Healthcare Services
$371.00B-1.0%
P/E 29.0·P/S 0.8·Mgn 2.8%·ROE 12.0%·FCF 4.3%
F 6
04
MRKMerck & Co., Inc.⚡
Healthcare · Pharmaceuticals
$294.03B-0.7%
P/E 32.9·P/S 4.5·Mgn 13.6%·ROE 34.7%·FCF 4.2%
F 4
05
AZNASTRAZENECA PLC🔥
Healthcare · Pharmaceuticals
$277.22B-0.7%
P/E 46.5·P/S 6.1·Mgn 13.0%·ROE 21.0%·FCF 4.2%
—
06
GLWCORNING INC /NY🔥
Materials · Metals & Mining
$154.23B-0.1%
P/E 78.5·P/S 9.4·Mgn 12.0%·ROE 13.5%·FCF —
F 6
Dilut.
07
VRTXVERTEX PHARMACEUTICALS INC / MA🔥
Healthcare · Pharmaceuticals
$112.92B-0.6%
P/E 26.0·P/S 9.2·Mgn 35.5%·ROE 21.2%·FCF 2.8%
F 6
Red 8-K
08
MCKMCKESSON CORP⚡
Healthcare · Healthcare Services
$94.25B+1.1%
P/E 18.5·P/S 0.2·Mgn 1.3%·ROE —·FCF 6.1%
F 7
09
ALNYALNYLAM PHARMACEUTICALS, INC.⚡
Healthcare · Pharmaceuticals
$37.76B+2.6%
P/E 120.4·P/S 10.2·Mgn 8.4%·ROE 39.8%·FCF 1.2%
F 6
Red 8-K
10
AAGILENT TECHNOLOGIES, INC.🔥
Healthcare · Diagnostics & Tools
$36.67B0.0%
P/E 25.9·P/S 5.1·Mgn 19.6%·ROE 19.3%·FCF 3.1%
F 5
Red 8-K
11
WATWATERS CORP /DE/⚡
Healthcare · Diagnostics & Tools
$34.91B+1.7%
P/E 54.3·P/S 11.0·Mgn 20.3%·ROE 25.1%·FCF 1.5%
F 4
12
NTRANatera, Inc.🔥
Healthcare · Healthcare Services
$30.37B-0.3%
P/E —·P/S 12.1·Mgn -9.0%·ROE -12.2%·FCF 0.4%
—
Red 8-K
13
IQVIQVIA HOLDINGS INC.⚡
Healthcare · Biotechnology
$30.29B-0.0%
P/E 22.3·P/S 1.9·Mgn 8.3%·ROE 20.9%·FCF 6.8%
—
Red 8-K
14
BIIBBIOGEN INC.
Healthcare · Biotechnology
$29.53B-0.3%
P/E 21.5·P/S 3.0·Mgn 13.8%·ROE 7.1%·FCF 6.9%
F 5
13D
15
DOVDOVER Corp⚡
Industrials · Machinery
$29.28B+0.1%
P/E 26.6·P/S 3.5·Mgn 13.3%·ROE 14.8%·FCF 3.8%
F 5
16
UTHRUNITED THERAPEUTICS Corp⚡
Healthcare · Pharmaceuticals
$23.17B-0.6%
P/E 18.0·P/S 7.3·Mgn 40.6%·ROE 18.8%·FCF 4.5%
F 8
Red 8-K
17
LHLABCORP HOLDINGS INC.⚡
Healthcare · Healthcare Services
$21.83B+0.1%
P/E 23.2·P/S 1.5·Mgn 6.7%·ROE 10.2%·FCF 5.5%
F 8
18
INSMINSMED Inc
Healthcare · Pharmaceuticals
$21.21B+1.8%
P/E —·P/S 25.9·Mgn -144.4%·ROE -172.8%·FCF -4.6%
F 4
19
MRNAModerna, Inc.🔥
Healthcare · Biotechnology
$19.80B+0.5%
P/E —·P/S 8.9·Mgn -143.6%·ROE -32.6%·FCF -10.4%
F 3
20
GHGuardant Health, Inc.🔥
Healthcare · Healthcare Services
$17.45B-2.4%
P/E —·P/S 16.2·Mgn -40.1%·ROE —·FCF -1.3%
F 5
Red 8-K
21
NBIXNEUROCRINE BIOSCIENCES INC
Healthcare · Biotechnology
$16.06B-0.9%
P/E 24.0·P/S 5.2·Mgn 21.6%·ROE 14.7%·FCF 4.7%
F 6
Red 8-K
22
EXELEXELIXIS, INC.
Healthcare · Biotechnology
$13.35B+0.2%
P/E 25.6·P/S 6.2·Mgn 24.0%·ROE 36.2%·FCF 6.6%
F 6
Red 8-K
23
BBIOBridgeBio Pharma, Inc.
Healthcare · Pharmaceuticals
$13.08B+3.4%
P/E —·P/S 22.6·Mgn -125.9%·ROE —·FCF -3.4%
F 2
13DRed 8-K
24
IONSIONIS PHARMACEUTICALS INC
Healthcare · Pharmaceuticals
$12.11B-1.7%
P/E —·P/S 11.4·Mgn -30.9%·ROE -78.0%·FCF -2.6%
F 3
Red 8-K
25
RVTYREVVITY, INC.🔥
Healthcare · Diagnostics & Tools
$11.12B+0.0%
P/E 46.1·P/S 3.9·Mgn 8.4%·ROE 3.3%·FCF 4.6%
—
26
MDGLMADRIGAL PHARMACEUTICALS, INC.
Healthcare · Pharmaceuticals
$11.08B+1.8%
P/E —·P/S 9.8·Mgn -27.3%·ROE -47.8%·FCF -1.7%
—
Red 8-K
27
RDYDR REDDYS LABORATORIES LTD
Healthcare · Pharmaceuticals
$11.07B-2.5%
P/E 16.5·P/S 2.9·Mgn 17.6%·ROE 17.0%·FCF 2.0%
—
28
SMMTSummit Therapeutics Inc.
Healthcare · Pharmaceuticals
$10.87B+1.8%
P/E —·P/S —·Mgn —·ROE -163.9%·FCF —
—
29
BMRNBIOMARIN PHARMACEUTICAL INC
Healthcare · Pharmaceuticals
$10.81B-0.8%
P/E 40.2·P/S 3.3·Mgn 8.3%·ROE 5.7%·FCF 6.7%
F 4
Red 8-K
30
ARWRARROWHEAD PHARMACEUTICALS, INC.
Healthcare · Pharmaceuticals
$10.50B+1.3%
P/E —·P/S 16.9·Mgn -43.7%·ROE -0.3%·FCF 1.5%
—
Red 8-K
31
DCIDONALDSON Co INC
Industrials · Machinery
$10.01B+1.6%
P/E 22.8·P/S 2.6·Mgn 11.5%·ROE 25.2%·FCF 3.4%
F 6
32
KRYSKrystal Biotech, Inc.⚡
Healthcare · Biotechnology
$9.37B-1.7%
P/E 41.7·P/S 22.5·Mgn 53.9%·ROE 16.8%·FCF 2.0%
—
33
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.🔥
Healthcare · Biotechnology
$9.03B+0.5%
P/E —·P/S 2.2·Mgn -4.5%·ROE -4.6%·FCF 5.7%
—
Red 8-K
34
TECHBIO-TECHNE Corp🔥
Healthcare · Biotechnology
$8.45B-0.3%
P/E 77.2·P/S 7.0·Mgn 9.0%·ROE 3.8%·FCF 3.0%
F 5
Red 8-K
35
PRAXPraxis Precision Medicines, Inc.⚡
Healthcare · Pharmaceuticals
$7.43B-4.5%
P/E —·P/S —·Mgn —·ROE -34.5%·FCF -3.4%
—
36
RGENREPLIGEN CORP
Healthcare · Biotechnology
$7.37B-0.4%
P/E 143.3·P/S 9.7·Mgn 6.7%·ROE 2.3%·FCF 1.3%
F 7
37
KYMRKymera Therapeutics, Inc.🔥
Healthcare · Biotechnology
$7.09B+4.9%
P/E —·P/S 180.8·Mgn -794.0%·ROE -19.7%·FCF -3.3%
F 4
13DRed 8-K
38
PTCTPTC THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$6.23B0.0%
P/E —·P/S 7.5·Mgn -22.6%·ROE —·FCF 11.3%
—
Dilut.Red 8-K
39
RYTMRHYTHM PHARMACEUTICALS, INC.⚡
Healthcare · Pharmaceuticals
$6.06B+0.9%
P/E —·P/S 27.9·Mgn -93.3%·ROE -141.3%·FCF -1.9%
F 6
Red 8-K
40
MIRMMirum Pharmaceuticals, Inc.
Healthcare · Pharmaceuticals
$6.06B-4.8%
P/E —·P/S 10.6·Mgn -140.2%·ROE -7.4%·FCF 0.9%
—
Dilut.
41
SRRKScholar Rock Holding Corp
Healthcare · Biotechnology
$5.29B+0.1%
P/E —·P/S —·Mgn —·ROE -154.0%·FCF -5.7%
—
42
CAICaris Life Sciences, Inc.
Healthcare · Healthcare Services
$5.08B-2.7%
P/E 149.5·P/S 5.6·Mgn 3.7%·ROE -11.8%·FCF 1.3%
—
43
CRSPCRISPR Therapeutics AG⚡
Healthcare · Biotechnology
$4.90B-3.2%
P/E —·P/S 1195.3·Mgn -13856.5%·ROE -30.3%·FCF -7.1%
—
Dilut.Red 8-K
44
TVTXTravere Therapeutics, Inc.⚡
Healthcare · Pharmaceuticals
$4.84B-2.6%
P/E —·P/S 9.0·Mgn -4.0%·ROE -22.2%·FCF —
F 7
Dilut.Red 8-K
45
TWSTTwist Bioscience Corp
Healthcare · Biotechnology
$4.74B+4.6%
P/E —·P/S 11.6·Mgn -19.8%·ROE -16.4%·FCF -1.6%
F 4
46
BLLNBillionToOne, Inc.⚡
Healthcare · Healthcare Services
$4.65B-0.3%
P/E 158.1·P/S 13.1·Mgn 8.3%·ROE 1.6%·FCF 0.3%
F 7
47
DNTHDianthus Therapeutics, Inc. /DE/⚡
Healthcare · Pharmaceuticals
$4.49B+1.9%
P/E —·P/S 2203.6·Mgn -7973.3%·ROE -32.9%·FCF —
—
48
CELCCelcuity Inc.⚡
Healthcare · Healthcare Services
$4.32B+2.0%
P/E —·P/S —·Mgn —·ROE -176.1%·FCF —
—
13DRed 8-K
49
ORKAOruka Therapeutics, Inc.
Healthcare · Pharmaceuticals
$4.22B+2.9%
P/E —·P/S —·Mgn —·ROE -22.3%·FCF —
—
13D
50
EWTXEdgewise Therapeutics, Inc.⚡
Healthcare · Pharmaceuticals
$3.75B-0.7%
P/E —·P/S —·Mgn —·ROE -32.1%·FCF —
—
13D
51
DNLIDenali Therapeutics Inc.
Healthcare · Biotechnology
$3.44B-0.7%
P/E —·P/S —·Mgn —·ROE -50.6%·FCF -12.3%
—
52
ALMSALUMIS INC.
Healthcare · Pharmaceuticals
$3.08B+3.7%
P/E —·P/S 366.5·Mgn -2825.7%·ROE -80.8%·FCF -12.0%
—
13D
53
ADPTAdaptive Biotechnologies Corp
Healthcare · Biotechnology
$2.82B+0.2%
P/E —·P/S 9.5·Mgn -16.8%·ROE -27.2%·FCF -1.7%
F 6
Dilut.
54
RAREUltragenyx Pharmaceutical Inc.
Healthcare · Pharmaceuticals
$2.40B+8.8%
P/E —·P/S 3.6·Mgn -90.9%·ROE —·FCF -19.7%
—
Red 8-K
55
KODKodiak Sciences Inc.
Healthcare · Biotechnology
$2.13B+3.2%
P/E —·P/S —·Mgn —·ROE -146.1%·FCF —
—
56
IMNMImmunome Inc.
Healthcare · Pharmaceuticals
$2.08B+0.7%
P/E —·P/S 518.4·Mgn -5593.8%·ROE -33.5%·FCF -9.6%
—
57
HRMYHarmony Biosciences Holdings, Inc.
Healthcare · Pharmaceuticals
$1.99B+3.0%
P/E 13.7·P/S 2.2·Mgn 16.2%·ROE 18.2%·FCF 17.4%
F 5
Red 8-K
58
IOVAIOVANCE BIOTHERAPEUTICS, INC.
Healthcare · Biotechnology
$1.82B-1.2%
P/E —·P/S 1532.2·Mgn -37345.4%·ROE -56.0%·FCF -18.5%
F 2
59
NRIXNurix Therapeutics, Inc.🔥
Healthcare · Pharmaceuticals
$1.75B+1.7%
P/E —·P/S 24.4·Mgn -411.4%·ROE —·FCF —
—
60
AGIOAGIOS PHARMACEUTICALS, INC.
Healthcare · Pharmaceuticals
$1.75B-2.4%
P/E —·P/S 26.5·Mgn -639.8%·ROE -34.6%·FCF -21.5%
F 2
Red 8-K
61
QUREuniQure N.V.🔥
Healthcare · Pharmaceuticals
$1.74B-2.8%
P/E —·P/S 96.1·Mgn -1154.4%·ROE -100.0%·FCF -10.3%
F 4
Red 8-K
62
NTLAIntellia Therapeutics, Inc.⚡
Healthcare · Diagnostics & Tools
$1.69B+1.9%
P/E —·P/S 25.6·Mgn -597.0%·ROE -61.5%·FCF -23.4%
—
63
INVAInnoviva, Inc.
Healthcare · Pharmaceuticals
$1.68B-1.9%
P/E 6.2·P/S 4.1·Mgn 65.9%·ROE 23.1%·FCF 11.7%
F 5
Red 8-K
64
RXRXRECURSION PHARMACEUTICALS, INC.
Healthcare · Biotechnology
$1.67B-0.5%
P/E —·P/S 22.4·Mgn -863.4%·ROE -57.0%·FCF -22.6%
F 4
Red 8-K
65
TSHATaysha Gene Therapies, Inc.
Healthcare · Biotechnology
$1.64B+1.2%
P/E —·P/S 219.6·Mgn -1738.4%·ROE -44.1%·FCF -5.7%
—
66
CMPSCOMPASS Pathways plc
Healthcare · Pharmaceuticals
$1.63B-6.1%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
67
AMLXAmylyx Pharmaceuticals, Inc.
Healthcare · Pharmaceuticals
$1.62B-4.0%
P/E —·P/S —·Mgn —·ROE -47.4%·FCF -7.6%
—
68
SIONSionna Therapeutics, Inc.
Healthcare · Pharmaceuticals
$1.62B+2.4%
P/E —·P/S —·Mgn —·ROE -24.5%·FCF —
—
13D
69
SRPTSarepta Therapeutics, Inc.
Healthcare · Pharmaceuticals
$1.62B+5.6%
P/E —·P/S 0.7·Mgn -32.5%·ROE -62.5%·FCF -19.0%
—
Red 8-K
70
PGENPRECIGEN, INC.
Healthcare · Pharmaceuticals
$1.59B-3.7%
P/E —·P/S 50.2·Mgn -647.0%·ROE -1198.6%·FCF -5.7%
—
13DRed 8-K
71
FTREFortrea Holdings Inc.
Healthcare · Healthcare Services
$1.56B-0.7%
P/E —·P/S 0.6·Mgn -16.5%·ROE -175.0%·FCF 5.7%
—
Red 8-K
72
SLSSELLAS Life Sciences Group, Inc.
Healthcare · Pharmaceuticals
$1.54B-4.5%
P/E —·P/S —·Mgn —·ROE -37.9%·FCF —
—
Red 8-K
73
CAPRCAPRICOR THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$1.49B+1.2%
P/E —·P/S 67.1·Mgn -181.7%·ROE -34.4%·FCF -4.9%
—
74
NEONEOGENOMICS INC
Industrials · Professional Services
$1.45B+2.4%
P/E —·P/S 2.0·Mgn -14.9%·ROE -12.9%·FCF -1.5%
F 5
Dilut.Red 8-K
75
AVBPArriVent BioPharma, Inc.
Healthcare · Pharmaceuticals
$1.42B+1.1%
P/E —·P/S —·Mgn —·ROE -54.1%·FCF —
—
76
MLTXMoonLake Immunotherapeutics
Healthcare · Pharmaceuticals
$1.38B-2.2%
P/E —·P/S —·Mgn —·ROE -75.6%·FCF —
—
13DRed 8-K
77
BLFSBIOLIFE SOLUTIONS INC
Healthcare · Medical Devices
$1.28B-0.2%
P/E —·P/S 12.8·Mgn -3.0%·ROE -1.2%·FCF 0.8%
F 6
13D
78
CDNACareDx, Inc.
Healthcare · Healthcare Services
$1.19B-2.7%
P/E —·P/S 2.9·Mgn -2.0%·ROE -7.0%·FCF —
—
Red 8-K
79
WVEWave Life Sciences Ltd.
Healthcare · Pharmaceuticals
$1.13B+2.3%
P/E —·P/S 15.7·Mgn -255.7%·ROE -39.4%·FCF -16.7%
—
13D
80
AZTAAzenta, Inc.
Industrials · Machinery
$1.04B+0.0%
P/E —·P/S 1.7·Mgn -29.1%·ROE -3.2%·FCF 3.7%
F 6
Red 8-K
81
PCRXPacira BioSciences, Inc.
Healthcare · Pharmaceuticals
$905M+1.1%
P/E 128.6·P/S 1.2·Mgn 1.0%·ROE 1.0%·FCF 15.1%
F 9
13DRed 8-K
82
PHARPharming Group N.V.
Healthcare · Pharmaceuticals
$904M+3.7%
P/E —·P/S 3.7·Mgn -4.3%·ROE 0.9%·FCF 6.0%
—
83
MGTXMeiraGTx Holdings plc
Healthcare · Biotechnology
$888M+7.7%
P/E —·P/S 11.1·Mgn -151.1%·ROE —·FCF -5.7%
—
13D
84
OLMAOlema Pharmaceuticals, Inc.
Healthcare · Pharmaceuticals
$862M+2.5%
P/E —·P/S —·Mgn —·ROE -33.9%·FCF —
—
Red 8-K
85
LXRXLEXICON PHARMACEUTICALS, INC.
Healthcare · Pharmaceuticals
$853M-9.1%
P/E —·P/S 12.2·Mgn -37.5%·ROE -46.8%·FCF -8.0%
F 4
13DDilut.
86
ABUSArbutus Biopharma Corp
Healthcare · Pharmaceuticals
$842M+2.6%
P/E 5.2·P/S 4.4·Mgn 84.0%·ROE -43.7%·FCF -4.7%
—
13DRed 8-K
87
JANXJanux Therapeutics, Inc.
Healthcare · Pharmaceuticals
$827M+0.2%
P/E —·P/S 60.2·Mgn -833.6%·ROE -11.9%·FCF -10.1%
—
Red 8-K
88
BIOABioAge Labs, Inc.
Healthcare · Pharmaceuticals
$802M-1.8%
P/E —·P/S 77.7·Mgn -871.8%·ROE -29.6%·FCF -10.3%
—
89
ZVRAZEVRA THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$748M+2.4%
P/E 9.0·P/S 7.0·Mgn 78.2%·ROE 53.8%·FCF -0.3%
—
90
SANASana Biotechnology, Inc.
Healthcare · Biotechnology
$746M+1.2%
P/E —·P/S —·Mgn —·ROE -151.8%·FCF —
—
Red 8-K
91
CYRXCryoport, Inc.
Healthcare · Pharmaceuticals
$737M-3.6%
P/E 9.4·P/S 4.2·Mgn 44.4%·ROE 15.6%·FCF -3.4%
F 5
92
REPLReplimune Group, Inc.
Healthcare · Biotechnology
$733M-1.2%
P/E —·P/S —·Mgn —·ROE -59.5%·FCF —
—
93
SLDBSolid Biosciences Inc.
Healthcare · Biotechnology
$703M+5.5%
P/E —·P/S —·Mgn —·ROE -96.8%·FCF —
—
13DDilut.Red 8-K
94
CRMDCorMedix Inc.
Healthcare · Pharmaceuticals
$686M+2.8%
P/E 3.8·P/S 1.7·Mgn 45.2%·ROE 40.2%·FCF 25.2%
F 5
95
ALLOAllogene Therapeutics, Inc.
Healthcare · Biotechnology
$656M-6.3%
P/E —·P/S —·Mgn —·ROE -65.3%·FCF -22.8%
—
Red 8-K
96
CTMXCytomX Therapeutics, Inc.
Healthcare · Pharmaceuticals
$655M+0.3%
P/E —·P/S 18.4·Mgn -166.4%·ROE -17.5%·FCF -11.6%
—
Red 8-K
97
CSTLCASTLE BIOSCIENCES INC
Healthcare · Healthcare Services
$628M-1.9%
P/E —·P/S 1.8·Mgn -3.8%·ROE -5.1%·FCF 4.5%
F 2
98
CADLCandel Therapeutics, Inc.
Healthcare · Biotechnology
$627M-0.6%
P/E —·P/S —·Mgn —·ROE -73.5%·FCF —
—
13DRed 8-K
99
RIGLRIGEL PHARMACEUTICALS INC
Healthcare · Pharmaceuticals
$608M+0.2%
P/E 1.7·P/S 2.0·Mgn 121.5%·ROE 93.8%·FCF —
F 6
Red 8-K
100
GYREGYRE THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$575M+2.2%
P/E —·P/S 4.9·Mgn -1.2%·ROE 9.3%·FCF -0.0%
F 4
13DDilut.Red 8-K
101
ZSQRZ Squared Inc.
Financials · Banks
$562M-9.3%
P/E —·P/S —·Mgn —·ROE -87.9%·FCF —
—
13DDilut.Red 8-K
102
FLGTFulgent Genetics, Inc.
Healthcare · Healthcare Services
$531M-0.1%
P/E —·P/S 1.7·Mgn -23.4%·ROE -5.4%·FCF -23.4%
F 3
13DRed 8-K
103
CTKBCytek Biosciences, Inc.
Healthcare · Diagnostics & Tools
$511M+2.1%
P/E —·P/S 2.5·Mgn -33.0%·ROE -19.5%·FCF -1.7%
F 3
Red 8-K
104
PRMEPrime Medicine, Inc.
Healthcare · Biotechnology
$501M-0.8%
P/E —·P/S 124.2·Mgn -4917.6%·ROE -166.4%·FCF -33.3%
—
Red 8-K
105
CBIOCRESCENT BIOPHARMA, INC.
Healthcare · Pharmaceuticals
$494M0.0%
P/E —·P/S 41.6·Mgn -782.5%·ROE -75.8%·FCF -14.7%
—
106
CABACabaletta Bio, Inc.
Healthcare · Biotechnology
$491M0.0%
P/E —·P/S —·Mgn —·ROE -149.8%·FCF —
—
107
ARVNARVINAS, INC.
Healthcare · Pharmaceuticals
$489M+0.2%
P/E —·P/S 6.2·Mgn -467.9%·ROE -18.6%·FCF -56.4%
—
Red 8-K
108
AGMBAgomab Therapeutics NV
Healthcare · Biotechnology
$473M-27.2%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
109
STTKShattuck Labs, Inc.
Healthcare · Pharmaceuticals
$472M+1.3%
P/E —·P/S 471.8·Mgn -4987.4%·ROE -59.2%·FCF -8.5%
—
13DRed 8-K
110
FDMT4D Molecular Therapeutics, Inc.
Healthcare · Biotechnology
$462M+3.3%
P/E —·P/S 5.2·Mgn -182.3%·ROE -27.7%·FCF -23.7%
—
111
NGNENeurogene Inc.
Healthcare · Pharmaceuticals
$460M-2.6%
P/E —·P/S —·Mgn —·ROE -34.1%·FCF -17.0%
—
Red 8-K
112
CTNMContineum Therapeutics, Inc.
Healthcare · Pharmaceuticals
$444M+9.3%
P/E —·P/S —·Mgn —·ROE -23.0%·FCF —
—
113
PRTAPROTHENA CORP PUBLIC LTD CO
Healthcare · Pharmaceuticals
$432M-1.8%
P/E —·P/S 7.5·Mgn -260.9%·ROE -87.0%·FCF —
—
114
CCCCC4 Therapeutics, Inc.
Healthcare · Biotechnology
$431M+7.4%
P/E —·P/S 12.0·Mgn -292.1%·ROE -40.9%·FCF -23.0%
—
Red 8-K
115
EBSEmergent BioSolutions Inc.
Healthcare · Pharmaceuticals
$429M-0.9%
P/E —·P/S 0.6·Mgn -1.3%·ROE 10.1%·FCF 36.5%
F 7
Dilut.
116
AUTLAutolus Therapeutics plc
Healthcare · Biotechnology
$415M-3.0%
P/E —·P/S 5.5·Mgn -381.4%·ROE -161.4%·FCF -72.9%
F 2
Red 8-K
117
OCGNOcugen, Inc.🔥
Healthcare · Biotechnology
$410M-8.4%
P/E —·P/S 91.7·Mgn -1605.2%·ROE —·FCF -14.0%
—
Dilut.Red 8-K
118
MYGNMYRIAD GENETICS INC
Healthcare · Diagnostics & Tools
$409M-2.4%
P/E —·P/S 0.5·Mgn -48.2%·ROE -99.4%·FCF —
F 5
Red 8-K
119
IPSCCentury Therapeutics, Inc.
Healthcare · Biotechnology
$406M+1.7%
P/E —·P/S —·Mgn —·ROE -6.0%·FCF -25.8%
—
Red 8-K
120
INDPIndaptus Therapeutics, Inc.
Healthcare · Pharmaceuticals
$405M-2.0%
P/E —·P/S —·Mgn —·ROE -127.7%·FCF —
—
13DDilut.Red 8-K
121
SGMTSagimet Biosciences Inc.
Healthcare · Pharmaceuticals
$400M-0.8%
P/E —·P/S —·Mgn —·ROE -45.8%·FCF —
—
Red 8-K
122
BNTCBenitec Biopharma Inc.
Healthcare · Pharmaceuticals
$384M+5.3%
P/E —·P/S —·Mgn —·ROE -39.0%·FCF —
—
Red 8-K
123
EDITEditas Medicine, Inc.
Healthcare · Biotechnology
$384M+1.3%
P/E —·P/S 9.9·Mgn -281.6%·ROE -586.6%·FCF -43.2%
—
Red 8-K
124
PBYIPUMA BIOTECHNOLOGY, INC.
Healthcare · Pharmaceuticals
$373M-1.0%
P/E 15.3·P/S 1.6·Mgn 10.7%·ROE 23.9%·FCF 11.2%
F 7
125
LRMRLarimar Therapeutics, Inc.
Healthcare · Pharmaceuticals
$360M-4.7%
P/E —·P/S —·Mgn —·ROE -212.2%·FCF —
—
126
VNDAVanda Pharmaceuticals Inc.
Healthcare · Pharmaceuticals
$353M-0.3%
P/E —·P/S 1.6·Mgn -110.0%·ROE -67.4%·FCF -31.3%
—
Red 8-K
127
ZURAZura Bio Ltd
Healthcare · Biotechnology
$351M+4.8%
P/E —·P/S —·Mgn —·ROE -67.6%·FCF —
—
Red 8-K
128
RGNXREGENXBIO Inc.⚡
Healthcare · Biotechnology
$344M+1.3%
P/E —·P/S 3.9·Mgn -330.2%·ROE -188.7%·FCF -36.7%
—
129
LXEOLexeo Therapeutics, Inc.
Healthcare · Biotechnology
$343M-3.2%
P/E —·P/S —·Mgn —·ROE -40.5%·FCF —
—
Red 8-K
130
IRDOpus Genetics, Inc.
Healthcare · Pharmaceuticals
$334M+1.2%
P/E —·P/S 23.5·Mgn -349.3%·ROE -323.1%·FCF —
—
13DDilut.Red 8-K
131
ABEOABEONA THERAPEUTICS INC.
Healthcare · Pharmaceuticals
$315M+9.2%
P/E —·P/S —·Mgn —·ROE 44.7%·FCF -26.7%
—
Red 8-K
132
LYELLyell Immunopharma, Inc.
Healthcare · Pharmaceuticals
$315M+10.2%
P/E —·P/S —·Mgn —·ROE -110.6%·FCF -47.9%
—
133
CLLSCellectis S.A.
Healthcare · Biotechnology
$311M+2.0%
P/E —·P/S —·Mgn —·ROE -89.1%·FCF -13.4%
—
134
PALIPALISADE BIO, INC.
Healthcare · Biotechnology
$297M-6.3%
P/E —·P/S —·Mgn —·ROE -13.0%·FCF —
—
Red 8-K
135
NAUTNautilus Biotechnology, Inc.
Healthcare · Diagnostics & Tools
$285M+4.5%
P/E —·P/S —·Mgn —·ROE -37.6%·FCF —
—
13D
136
NVCTNuvectis Pharma, Inc.
Healthcare · Pharmaceuticals
$284M-35.5%
P/E —·P/S —·Mgn —·ROE -143.6%·FCF —
—
137
ELTXElicio Therapeutics, Inc.
Healthcare · Pharmaceuticals
$283M-2.3%
P/E —·P/S —·Mgn —·ROE -2418.8%·FCF —
—
138
BCYCBICYCLE THERAPEUTICS PLC
Healthcare · Pharmaceuticals
$283M+2.2%
P/E —·P/S 10.0·Mgn -884.5%·ROE -35.9%·FCF -89.1%
—
139
RNACCartesian Therapeutics, Inc.
Healthcare · Pharmaceuticals
$279M+8.1%
P/E —·P/S 99.9·Mgn -4658.6%·ROE —·FCF -28.4%
—
13DDilut.Red 8-K
140
ARMPArmata Pharmaceuticals, Inc.
Healthcare · Biotechnology
$278M+0.3%
P/E —·P/S 56.7·Mgn -3544.0%·ROE —·FCF —
—
13DRed 8-K
141
IMRXImmuneering Corp
Healthcare · Pharmaceuticals
$271M-1.2%
P/E —·P/S —·Mgn —·ROE -25.6%·FCF —
—
Red 8-K
142
TRDAEntrada Therapeutics, Inc.
Healthcare · Pharmaceuticals
$251M-4.5%
P/E —·P/S 43.7·Mgn -2895.1%·ROE -47.0%·FCF -51.7%
—
Red 8-K
143
FHTXFoghorn Therapeutics Inc.
Healthcare · Pharmaceuticals
$245M+0.4%
P/E —·P/S 7.9·Mgn -240.3%·ROE —·FCF -35.1%
—
144
FATEFATE THERAPEUTICS INC
Healthcare · Biotechnology
$240M+11.6%
P/E —·P/S 38.0·Mgn -2056.8%·ROE -65.8%·FCF -46.7%
—
13DRed 8-K
145
AVXLANAVEX LIFE SCIENCES CORP.
Healthcare · Biotechnology
$232M-0.4%
P/E —·P/S 49.5·Mgn -991.4%·ROE -48.9%·FCF —
—
Red 8-K
146
TARAProtara Therapeutics, Inc.
Healthcare · Biotechnology
$219M-8.2%
P/E —·P/S —·Mgn —·ROE -29.2%·FCF —
—
Red 8-K
147
CDXSCODEXIS, INC.
Materials · Chemicals
$218M-3.0%
P/E —·P/S 2.8·Mgn -41.0%·ROE -87.0%·FCF -10.9%
F 4
Red 8-K
148
CAMPCamp4 Therapeutics Corp
Healthcare · Pharmaceuticals
$218M-1.6%
P/E —·P/S 55.3·Mgn -2193.7%·ROE -168.5%·FCF -13.7%
—
13DRed 8-K
149
RNAAtrium Therapeutics, Inc.
Healthcare · Pharmaceuticals
$212M-1.5%
P/E —·P/S 11.3·Mgn -3650.4%·ROE -40.5%·FCF —
—
150
VYGRVoyager Therapeutics, Inc.
Healthcare · Biotechnology
$211M-2.2%
P/E —·P/S 5.8·Mgn -319.6%·ROE -61.1%·FCF -63.9%
—
Red 8-K
151
WHWKWhitehawk Therapeutics, Inc.
Healthcare · Pharmaceuticals
$206M+3.9%
P/E —·P/S 28.8·Mgn -288.3%·ROE -15.1%·FCF -47.6%
F 4
13DDilut.
152
NKTXNkarta, Inc.
Healthcare · Pharmaceuticals
$205M-0.7%
P/E —·P/S —·Mgn —·ROE -33.3%·FCF -43.9%
—
13D
153
KROSKeros Therapeutics, Inc.
Healthcare · Pharmaceuticals
$201M-2.1%
P/E 2.3·P/S 0.8·Mgn 35.7%·ROE 28.7%·FCF 52.7%
—
Red 8-K
154
ARCTArcturus Therapeutics Holdings Inc.
Healthcare · Pharmaceuticals
$198M-1.5%
P/E —·P/S 3.6·Mgn -143.8%·ROE -30.7%·FCF -37.6%
—
Red 8-K
155
CGENCOMPUGEN LTD
Healthcare · Biotechnology
$193M-0.9%
P/E —·P/S —·Mgn —·ROE 34.4%·FCF 16.2%
F 7
156
OTLKOutlook Therapeutics, Inc.
Healthcare · Biotechnology
$181M-5.9%
P/E —·P/S 128.2·Mgn -4312.3%·ROE —·FCF —
—
13DDilut.Red 8-K
157
TNXPTonix Pharmaceuticals Holding Corp.
Healthcare · Pharmaceuticals
$181M+0.1%
P/E —·P/S 10.3·Mgn -839.5%·ROE -50.6%·FCF -57.0%
F 5
Red 8-K
158
TTRXTurn Therapeutics Inc.
Healthcare · Pharmaceuticals
$180M+5.6%
P/E —·P/S —·Mgn —·ROE -68.2%·FCF —
—
Dilut.
159
GALTGALECTIN THERAPEUTICS INC
Healthcare · Pharmaceuticals
$176M-6.6%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
160
ABOSAcumen Pharmaceuticals, Inc.
Healthcare · Biotechnology
$171M-3.6%
P/E —·P/S —·Mgn —·ROE -172.3%·FCF —
—
13DDilut.
161
OKUROnKure Therapeutics, Inc.
Healthcare · Pharmaceuticals
$170M+1.3%
P/E —·P/S 49.4·Mgn -1733.7%·ROE -105.9%·FCF —
—
13DDilut.Red 8-K
162
PLXProtalix BioTherapeutics, Inc.
Healthcare · Biotechnology
$168M-0.8%
P/E 11.0·P/S 2.2·Mgn 20.1%·ROE -13.7%·FCF -8.1%
F 1
163
KZIAKAZIA THERAPEUTICS LTD
Healthcare · Pharmaceuticals
$163M-2.6%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
164
CRBUCaribou Biosciences, Inc.
Healthcare · Biotechnology
$158M-0.6%
P/E —·P/S 14.2·Mgn -1327.4%·ROE -121.2%·FCF -71.0%
—
165
DTILPRECISION BIOSCIENCES INC
Healthcare · Biotechnology
$157M-0.8%
P/E —·P/S 3.5·Mgn -96.7%·ROE -49.6%·FCF -41.9%
—
Red 8-K
166
MOLNMOLECULAR PARTNERS AG
Healthcare · Biotechnology
$154M-2.3%
P/E 1.1·P/S 0.7·Mgn 62.2%·ROE -76.7%·FCF -41.6%
—
167
PRQRProQR Therapeutics N.V.
Healthcare · Pharmaceuticals
$152M+1.6%
P/E —·P/S 98.3·Mgn -4490.3%·ROE -85.4%·FCF -40.4%
—
13D
168
HURATuHURA Biosciences, Inc./NV
Healthcare · Pharmaceuticals
$148M+2.2%
P/E —·P/S —·Mgn —·ROE -143.6%·FCF -18.8%
—
Dilut.Red 8-K
169
TLSATiziana Life Sciences Ltd
Healthcare · Pharmaceuticals
$140M+4.1%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
170
GNLXGENELUX Corp
Healthcare · Pharmaceuticals
$133M+3.8%
P/E —·P/S —·Mgn —·ROE -278.5%·FCF -19.9%
—
171
VTVTvTv Therapeutics Inc.
Healthcare · Pharmaceuticals
$129M+3.8%
P/E —·P/S 3.5·Mgn -2.0%·ROE -41.9%·FCF —
—
172
NTHINEONC TECHNOLOGIES HOLDINGS, INC.
Healthcare · Pharmaceuticals
$124M+2.3%
P/E —·P/S —·Mgn —·ROE —·FCF -16.9%
—
Dilut.
173
MXCTMAXCYTE, INC.
Healthcare · Biotechnology
$120M-0.8%
P/E —·P/S 3.6·Mgn -135.1%·ROE -26.0%·FCF -30.2%
F 2
13DRed 8-K
174
PLYXPolaryx Therapeutics, Inc.
Healthcare · Pharmaceuticals
$118M+5.1%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
Dilut.
175
RFLRafael Holdings, Inc.
Healthcare · Pharmaceuticals
$116M+3.8%
P/E —·P/S —·Mgn —·ROE -32.3%·FCF -16.3%
—
176
PYXSPyxis Oncology, Inc.
Healthcare · Pharmaceuticals
$112M+5.2%
P/E —·P/S 8.0·Mgn -589.8%·ROE -149.1%·FCF -57.0%
F 2
Red 8-K
177
CGTXCOGNITION THERAPEUTICS INC
Healthcare · Biotechnology
$108M+5.5%
P/E —·P/S —·Mgn —·ROE -68.5%·FCF —
—
178
LIXTLIXTE BIOTECHNOLOGY HOLDINGS, INC.
Healthcare · Pharmaceuticals
$108M-7.7%
P/E —·P/S —·Mgn —·ROE -54.8%·FCF —
—
Dilut.Red 8-K
179
BDTXBlack Diamond Therapeutics, Inc.
Healthcare · Biotechnology
$100M+5.7%
P/E —·P/S —·Mgn —·ROE 19.9%·FCF —
—
180
PTHSPelthos Therapeutics Inc.
Healthcare · Biotechnology
$96M+2.6%
P/E —·P/S 5.7·Mgn -257.9%·ROE -111.4%·FCF -23.7%
—
Red 8-K
181
VANIVivani Medical, Inc.
Healthcare · Medical Devices
$95M+2.5%
P/E —·P/S —·Mgn —·ROE -169.2%·FCF -26.9%
—
13D
182
PMNProMIS Neurosciences Inc.
Healthcare · Pharmaceuticals
$93M+22.4%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
Red 8-K
183
BNRBurning Rock Biotech Ltd
Healthcare · Healthcare Services
$91M+3.6%
P/E —·P/S 1.2·Mgn -10.3%·ROE -10.3%·FCF -5.3%
—
184
RPIDRAPID MICRO BIOSYSTEMS, INC.
Healthcare · Diagnostics & Tools
$88M0.0%
P/E —·P/S 2.6·Mgn -145.8%·ROE -141.9%·FCF -36.4%
—
185
ANIXAnixa Biosciences Inc
Healthcare · Pharmaceuticals
$84M-1.8%
P/E —·P/S —·Mgn —·ROE -79.1%·FCF —
—
186
IBIOiBio, Inc.
Healthcare · Pharmaceuticals
$84M+1.2%
P/E —·P/S —·Mgn —·ROE -123.5%·FCF -18.2%
—
Red 8-K
187
OKYOOKYO Pharma Ltd
Healthcare · Biotechnology
$80M-1.3%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
188
LONALeonaBio, Inc.
Healthcare · Biotechnology
$78M+3.7%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
13D
189
AGPUAxe Compute Inc.
Financials · Banks
$77M+0.5%
P/E —·P/S —·Mgn —·ROE -488.5%·FCF -12.8%
F 3
13DRed 8-K
190
ANVSAnnovis Bio, Inc.
Healthcare · Pharmaceuticals
$76M0.0%
P/E —·P/S —·Mgn —·ROE -171.2%·FCF —
—
191
ACETAdicet Bio, Inc.
Healthcare · Pharmaceuticals
$75M+0.9%
P/E —·P/S —·Mgn —·ROE -73.4%·FCF —
—
13DDilut.
192
CLNNClene Inc.
Healthcare · Pharmaceuticals
$75M-2.8%
P/E —·P/S —·Mgn —·ROE —·FCF -24.9%
F 1
Red 8-K
193
GANXGain Therapeutics, Inc.
Healthcare · Pharmaceuticals
$72M+2.5%
P/E —·P/S —·Mgn —·ROE -108.6%·FCF —
—
194
INKTMiNK Therapeutics, Inc.
Healthcare · Biotechnology
$60M-1.9%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
Filings · filterAll10-K10-Q8-KS-1DEF 14ASC 13D

Filings

40 shown
OLOXOLENOX INDUSTRIES INC.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 30, 2026·23h ago
AIHSSenmiao Technology Ltd
10-K

Annual report — full-year financials, business overview, and risk factors.

Companies above the $50M market cap · $1 pricefloor; SPAC/shells hidden by default. Fundamentals & prices via Polygon · signals from SEC EDGAR — verify on SEC.gov. Filings current to Jun 30 · prices to Jun 30.
Jun 30, 2026
·
23h ago
TEL INSTRUMENT ELECTRONICS CORP
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 30, 2026·1d ago
SCORES HOLDING CO INC
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 30, 2026·1d ago
BENFWBeneficient
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 30, 2026·1d ago
AGSSAMERIGUARD SECURITY SERVICES, INC.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
PETVWPetVivo Holdings, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
MODDModular Medical, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
21Shares Polkadot ETF
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
AVAVAeroVironment Inc
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
EZETFranklin Ethereum Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
EZBCFranklin Templeton Digital Holdings Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
FGDLFranklin Templeton Holdings Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
XRPZFranklin XRP Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
SOEZFranklin Solana Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
QDMIQDM International Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
PODCPodcastOne, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
LVOLiveOne, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
RDZNWRoadzen Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
ELTPELITE PHARMACEUTICALS INC /NV/
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
ATXGADDENTAX GROUP CORP.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
SUNDSundance Strategies, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
MEDICAL EXERCISE INC.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
GRVEGROOVE BOTANICALS INC.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
MMEDMiniMed Group, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
AIRTPAIR T INC
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
REPLReplimune Group, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
PMNTPerfect Moment Ltd.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
MXCMEXCO ENERGY CORP
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
KEQUKEWAUNEE SCIENTIFIC CORP /DE/
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·4d ago
KFYKORN FERRY
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·4d ago
XAIRBeyond Air, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·4d ago
MSNEMERSON RADIO CORP
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·4d ago
Nissan Auto Receivables 2025-B Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2025-A Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2024-B Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2024-A Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2023-B Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2023-A Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2022-B Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago